Related Experiment Video
Updated: Apr 28, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression
Xiaojuan Yang1,2, Zhiwei Zhang1,3, Shuangjuan Lv2
1Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.
WD repeat and HMG-box DNA-binding protein 1 (WDHD1) drives pancreatic cancer by promoting cell proliferation and cycle progression. Inhibiting WDHD1 suppresses tumor growth and induces apoptosis, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- WD repeat and HMG-box DNA-binding protein 1 (WDHD1) is an oncogene implicated in various cancers.
- The specific role and mechanisms of WDHD1 in pancreatic cancer progression were previously uninvestigated.
Purpose of the Study:
- To elucidate the function and molecular mechanisms of WDHD1 in pancreatic cancer.
- To determine the relationship between WDHD1, E2F1, and cell cycle regulators in pancreatic cancer.
Main Methods:
- Differential gene expression analysis using TCGA pancreatic cancer data.
- In vitro cellular assays (proliferation, flow cytometry, apoptosis) and in vivo xenograft models.
- Western blotting to assess protein levels of WDHD1, CDK4, cyclin D1, and E2F1.
Main Results:
- WDHD1 expression is significantly upregulated in pancreatic cancer tissues and cells.
- WDHD1 knockdown inhibits proliferation, induces apoptosis, and causes G1 cell-cycle arrest.
- WDHD1 promotes CDK4 and cyclin D1 expression; E2F1 upregulates WDHD1, driving cell cycle progression.
Conclusions:
- E2F1 promotes pancreatic cancer progression by upregulating WDHD1.
- WDHD1 enhances CDK4-cyclin D1 complex expression, driving proliferation and cell-cycle progression.
- Targeting WDHD1 may represent a novel therapeutic strategy for pancreatic cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
Negative Regulator Molecules
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Specific Gene Expression

